Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials
作者： K Bujko , R Glynne-Jones , M Bujko , None
关键词: Internal medicine 、 Chemotherapy regimen 、 Colorectal cancer 、 Cancer 、 Oncology 、 Combined Modality Therapy 、 Medicine 、 Surgery 、 Radiation therapy 、 Neoadjuvant therapy 、 Clinical trial 、 Chemoradiotherapy
摘要: Background The results of the recently published large European randomised study in rectal cancer (European Organisation for Research and Treatment of Cancer 22921 trial) do not …
oup.com
annalsofoncology.org
oxfordjournals.org
sci-hub.se 参考文章(56)
B G Taal, , H Van Tinteren, F A N Zoetmulder, Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. British Journal of Cancer. ,vol. 85, pp. 1437- 1443 ,(2001) , 10.1054/BJOC.2001.2117
R. Sabouraud, L'Hopital Saint-Louis Laboratoires Ciba. ,(1937)
L Ludeman, N A Shepherd, Serosal involvement in gastrointestinal cancer : its assessment and significance Histopathology. ,vol. 47, pp. 123- 131 ,(2005) , 10.1111/J.1365-2559.2005.02189.X
James E. Krook, Charles G. Moertel, Leonard L. Gunderson, Harry S. Wieand, Roger T. Collins, Robert W. Beart, Theodore P. Kubista, Michael A. Poon, William C. Meyers, James A. Mailliard, Donald I. Twito, Roscoe F. Morton, Michael H. Veeder, Thomas E. Witzig, Stephen Cha, Subhash C. Vidyarthi, Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma New England Journal of Medicine. ,vol. 324, pp. 709- 715 ,(1991) , 10.1056/NEJM199103143241101
WALTER LAWRENCE, JOSE J. TERZ, SHELTON HORSLEY, MILTON DONALDSON, WILLIAM L. LOVETT, PETER W. BROWN, B. W. RUFFNER, WILLIAM REGELSON, Chemotherapy as an adjuvant to surgery for colorectal cancer. Annals of Surgery. ,vol. 181, pp. 616- 623 ,(1975) , 10.1097/00000658-197505000-00016
I. Taylor, D. Machin, M. Mullee, G. Trotter, T. Cooke, C. West, A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. British Journal of Surgery. ,vol. 72, pp. 359- 363 ,(2005) , 10.1002/BJS.1800720509
L. Hafström, L. Domellöf, C.-M. Rudenstam, C. Norryd, L. Bergman, T. Nilsson, K. Hansson, L. Wählby, , Adjuvant chemotherapy with 5‐fluorouracil, vincristine and CCNU for patients with Dukes' C colorectal cancer British Journal of Surgery. ,vol. 77, pp. 1345- 1348 ,(2005) , 10.1002/BJS.1800771209
L. Hafström, C.-M. Rudenstam, L. Domellöf, , A randomized trial of oral 5-fluorouracil versus placebo as adjuvant therapy in colorectal cancer Dukes' B and C: results after 5 years observation time. British Journal of Surgery. ,vol. 72, pp. 138- 141 ,(2005) , 10.1002/BJS.1800720223
Arne Wibe, Astri Syse, Elisabeth Andersen, Steinar Tretli, Helge E Myrvold, Odd Søreide, Norwegian Rectal Cancer Group, Oncological Outcomes After Total Mesorectal Excision for Cure for Cancer of the Lower Rectum: Anterior vs. Abdominoperineal Resection Diseases of The Colon & Rectum. ,vol. 47, pp. 48- 58 ,(2004) , 10.1007/S10350-003-0012-Y
Gunilla Jansson Frykholm, Bengt Glimelius, Lars Påhlman, PREOPERATIVE OR POSTOPERATIVE IRRADIATION IN ADENOCARCINOMA OF THE RECTUM: FINAL TREATMENT RESULTS OF A RANDOMIZED TRIAL AND AN EVALUATION OF LATE SECONDARY EFFECTS Diseases of The Colon & Rectum. ,vol. 36, pp. 564- 572 ,(1993) , 10.1007/BF02049863